The common denominator is charisma and hubris on the part of the founder(s). Lots of investors go for that. I'd put the blame on the cult of the charismatic leader in business.
The common denominator is charisma and hubris on the part of the founder(s). Lots of investors go for that. I'd put the blame on the cult of the charismatic leader in business.
Theranos made fraudulent claims about their product, pressured themselves into the health care market, and violated hundreds of ethical guidelines. Not only were investors defrauded (oh well, its only money) - people used them in clinical scenarios and impacted actual healthcare patients. When people questioned these claims, the CEO publicly claimed criticism of her was sexist, and the media was complicit.
These two scenarios are vastly different.
a) Juicero is broke, and "piercing the corporate veil" is difficult and expensive.
b) It would show exactly how credulous the investors were, as well as their outstanding lack of initial and ongoing due diligence and oversight.
Also, Juicero failed because of poor product/market fit and excessive price. Theranos had fantastic product market fit, it's just their product didn't function properly and relied on lying to their investors, their customers and the FDA.